Azamjah N, Soltan-Zadeh Y, Zayeri F (2019) Global trend of breast cancer mortality rate: a 25-year study. Asian Pac J Cancer Prev 20:2015–2020

Article  PubMed  PubMed Central  Google Scholar 

Arnold M, Morgan E, Rumgay H et al (2022) Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 66:15–23

Article  PubMed  PubMed Central  Google Scholar 

Giaquinto AN, Sung H, Miller KD et al (2022) breast cancer statistics, 2022. CA Cancer J Clin 72:524–541

Article  PubMed  Google Scholar 

Kowalski AE (2021) Mammograms and Mortality: How Has the Evidence Evolved? J Econ Perspect 35:119–140

Article  PubMed  PubMed Central  Google Scholar 

Narod SA, Iqbal J, Miller AB (2015) Why have breast cancer mortality rates declined? J Cancer Policy 5:8–17

Article  Google Scholar 

Starikov A, Askin G, Blackburn A et al (2021) Mode of detection matters: Differences in screen-detected versus symptomatic breast cancers. Clin Imaging 80:11–15

Article  PubMed  Google Scholar 

Jörg I, Wieler J, Elfgen C et al (2021) Discrepancies between radiological and histological findings in preoperative core needle (CNB) and vacuum-assisted (VAB) breast biopsies. J Cancer Res Clin Oncol 147:749–754

Article  PubMed  Google Scholar 

Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665–676

Article  CAS  PubMed  Google Scholar 

Robson M, Im SA, Senkus E et al (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med 377:523–533

Article  CAS  PubMed  Google Scholar 

Bardou V-J, Arpino G, Elledge RM, Osborne CK, Clark GM (2003) Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 21:1973–1979

Article  CAS  PubMed  Google Scholar 

Tokunaga E, Masuda N, Yamamoto N et al (2021) Long-term outcomes of a randomized study of neoadjuvant induction dual HER2 blockade with trastuzumab and lapatinib followed by weekly paclitaxel plus dual HER2 blockade for HER2-Positive primary breast cancer (Neo-Lath Study). Cancers 13:4008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masoud V, Pagès G (2017) Targeted therapies in breast cancer: New challenges to fight against resistance. World J Clin Oncol 8:120–134

Article  PubMed  PubMed Central  Google Scholar 

Davies C, Godwin J, Gray R et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771–784

Article  CAS  PubMed  Google Scholar 

Ye F, Dewanjee S, Li Y et al (2023) Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer 22:105

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suganyadevi S, Seethalakshmi V, Balasamy K (2022) A review on deep learning in medical image analysis. Int J Multimedia Inf Retr 11:19–38

Article  CAS  Google Scholar 

Bitencourt A, Daimiel Naranjo I, Lo Gullo R, Rossi Saccarelli C, Pinker K (2021) AI-enhanced breast imaging: Where are we and where are we heading? Eur J Radiol 142:109882

Article  PubMed  PubMed Central  Google Scholar 

Davey MG, Davey MS, Boland MR, Ryan ÉJ, Lowery AJ, Kerin MJ (2021) Radiomic differentiation of breast cancer molecular subtypes using pre-operative breast imaging - A systematic review and meta-analysis. Eur J Radiol 144:109996

Article  PubMed  Google Scholar 

Sirjani N, Oghli MG, Tarzamni MK et al (2023) A novel deep learning model for breast lesion classification using ultrasound Images: A multicenter data evaluation. Physica Med 107:102560

Article  Google Scholar 

Mainta IC, Sfakianaki I, Shiri I, Botsikas D, Garibotto V (2023) The clinical added value of breast cancer imaging using hybrid PET/MR imaging. Magn Reson Imaging Clin N Am 31:565–577

Article  PubMed  Google Scholar 

Quanyang W, Yao H, Sicong W et al (2024) Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis. Cancer Med 13:e7140

Article  PubMed  PubMed Central  Google Scholar 

Bo Z, Song J, He Q et al (2024) Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma. Comput Biol Med 173:108337

Article  PubMed  Google Scholar 

Mei T, Wang T, Zhou Q (2024) Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients. Clin Exp Med 24:60

Article  PubMed  PubMed Central  Google Scholar 

Tagliafico AS, Piana M, Schenone D, Lai R, Massone AM, Houssami N (2020) Overview of radiomics in breast cancer diagnosis and prognostication. Breast 49:74–80

Article  PubMed  Google Scholar 

Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577

Article  PubMed  Google Scholar 

Saha A, Harowicz MR, Grimm LJ et al (2018) A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features. Br J Cancer 119:508–516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grimm LJ, Zhang J, Mazurowski MA (2015) Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms. J Magn Reson Imaging 42:902–907

Article  PubMed  Google Scholar 

Saha A, Harowicz MR, Grimm LJ, Weng J, Cain EH, Kim CE, Ghate SV, Walsh R, and Mazurowski MA (2021) Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/TCIA.e3sv-re93

Clark K, Vendt B, Smith K et al (2013) The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging 26:1045–1057

Article  PubMed  PubMed Central  Google Scholar 

Tustison NJ, Avants BB, Cook PA et al (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29:1310–1320

Article  PubMed  PubMed Central  Google Scholar 

Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87–97

Article  CAS  PubMed  Google Scholar 

Paszke A, Gross S, Massa F, Lerer A, Bradbury J, Chanan G, Killeen T, Lin Z, Gimelshein N, Antiga L, Desmaison A et al (2019) Pytorch: an imperative style, high-performance deep learning library. Advances in Neural Information Processing Systems, 32

Cardoso MJ, Li W, Brown R et al (2022) MONAI: An open-source framework for deep learning in healthcare. arXiv preprint arXiv:221102701

Ben-Dror J, Shalamov M, Sonnenblick A (2022) The history of early breast cancer treatment. Genes (Basel);13(6):960. https://doi.org/10.3390/genes13060960

Greenwalt I, Zaza N, Das S, Li BD (2020) Precision medicine and targeted therapies in breast cancer. Surg Oncol Clin N Am 29:51–62

Article  PubMed  Google Scholar 

Hurvitz SA, Hegg R, Chung WP et al (2023) Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial. Lancet 401:105–117

Article  CAS  PubMed  Google Scholar 

Cameron D, Piccart-Gebhart MJ, Gelber RD et al (2017) 11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet 389:1195–1205

Article  CAS  PubMed  PubMed Central